Skip to main content

RHUMBLINE ADVISERS

Position in STOK — Stoke Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in STOK

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,484,462
+$292,686 QoQ
Shares Held
75,931
+12.8% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 29% Shared 0% None 71%

Common Shares in STOK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. STOK ranks #86 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in STOK

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,484,462 75,931
2026-03-31 $2,191,776 67,315
2025-12-31 $1,981,020 62,414
2025-09-30 $1,605,144 68,304
2025-06-30 $753,855 66,419
2025-03-31 $329,833 49,599
2024-12-31 $544,595 49,374
2024-09-30 $572,554 46,587
2024-06-30 $646,588 47,860
2024-03-31 $565,245 41,870
2023-12-31 $215,507 40,971
2023-09-30 $161,575 41,009
2023-06-30 $448,320 42,175
2023-03-31 $288,193 34,597
2022-12-31 $315,582 34,191
2022-09-30 $432,913 33,716
2022-06-30 $420,751 31,851
2022-03-31 $407,212 19,345
2021-12-31 $431,412 17,983
2021-09-30 $466,035 18,319
2021-06-30 $588,040 17,470
2021-03-31 $602,291 15,507
2020-12-31 $970,566 15,672
2020-09-30 $494,379 14,762
2020-06-30 $402,178 16,877
2020-03-31 $462,992 20,218